These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 9418135)

  • 21. Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression.
    Kienzle N; Sculley TB; Poulsen L; Buck M; Cross S; Raab-Traub N; Khanna R
    J Virol; 1998 Aug; 72(8):6614-20. PubMed ID: 9658107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.
    Khanna R; Burrows SR; Steigerwald-Mullen PM; Thomson SA; Kurilla MG; Moss DJ
    Virology; 1995 Dec; 214(2):633-7. PubMed ID: 8553567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clonal composition of a peptide-specific oligoclonal CTL repertoire selected in response to persistent EBV infection is stable over time.
    Levitsky V; de Campos-Lima PO; Frisan T; Masucci MG
    J Immunol; 1998 Jul; 161(2):594-601. PubMed ID: 9670932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CTL recognition of a bulged viral peptide involves biased TCR selection.
    Miles JJ; Elhassen D; Borg NA; Silins SL; Tynan FE; Burrows JM; Purcell AW; Kjer-Nielsen L; Rossjohn J; Burrows SR; McCluskey J
    J Immunol; 2005 Sep; 175(6):3826-34. PubMed ID: 16148129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.
    Burrows SR; Khanna R; Burrows JM; Moss DJ
    J Exp Med; 1994 Apr; 179(4):1155-61. PubMed ID: 7511682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
    Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
    Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies.
    Schmidt C; Burrows SR; Sculley TB; Moss DJ; Misko IS
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9478-82. PubMed ID: 1719531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.
    Nowakowska J; Stuehler C; Egli A; Battegay M; Rauser G; Bantug GR; Brander C; Hess C; Khanna N
    Cytotherapy; 2015 Sep; 17(9):1280-91. PubMed ID: 26276009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changing patterns of dominant TCR usage with maturation of an EBV-specific cytotoxic T cell response.
    Annels NE; Callan MF; Tan L; Rickinson AB
    J Immunol; 2000 Nov; 165(9):4831-41. PubMed ID: 11046006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic T cell recognition of allelic variants of HLA B35 bound to an Epstein-Barr virus epitope: influence of peptide conformation and TCR-peptide interaction.
    Khanna R; Silins SL; Weng Z; Gatchell D; Burrows SR; Cooper L
    Eur J Immunol; 1999 May; 29(5):1587-97. PubMed ID: 10359113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epitope-dependent selection of highly restricted or diverse T cell receptor repertoires in response to persistent infection by Epstein-Barr virus.
    Campos-Lima PO; Levitsky V; Imreh MP; Gavioli R; Masucci MG
    J Exp Med; 1997 Jul; 186(1):83-9. PubMed ID: 9207000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4.
    Levitsky V; Zhang QJ; Levitskaya J; Masucci MG
    J Exp Med; 1996 Mar; 183(3):915-26. PubMed ID: 8642295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tetramer-assisted identification and characterization of epitopes recognized by HLA A*2402-restricted Epstein-Barr virus-specific CD8+ T cells.
    Kuzushima K; Hayashi N; Kudoh A; Akatsuka Y; Tsujimura K; Morishima Y; Tsurumi T
    Blood; 2003 Feb; 101(4):1460-8. PubMed ID: 12393434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation.
    Tynan FE; Elhassen D; Purcell AW; Burrows JM; Borg NA; Miles JJ; Williamson NA; Green KJ; Tellam J; Kjer-Nielsen L; McCluskey J; Rossjohn J; Burrows SR
    J Exp Med; 2005 Nov; 202(9):1249-60. PubMed ID: 16275762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accessing Epstein-Barr virus-specific T-cell memory with peptide-loaded dendritic cells.
    Redchenko IV; Rickinson AB
    J Virol; 1999 Jan; 73(1):334-42. PubMed ID: 9847337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A recombinant adenovirus expressing an Epstein-Barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro.
    Morgan SM; Wilkinson GW; Floettmann E; Blake N; Rickinson AB
    J Virol; 1996 Apr; 70(4):2394-402. PubMed ID: 8642667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues.
    de Campos-Lima PO; Levitsky V; Brooks J; Lee SP; Hu LF; Rickinson AB; Masucci MG
    J Exp Med; 1994 Apr; 179(4):1297-305. PubMed ID: 7511684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severity of Acute Infectious Mononucleosis Correlates with Cross-Reactive Influenza CD8 T-Cell Receptor Repertoires.
    Aslan N; Watkin LB; Gil A; Mishra R; Clark FG; Welsh RM; Ghersi D; Luzuriaga K; Selin LK
    mBio; 2017 Dec; 8(6):. PubMed ID: 29208744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+ T cells.
    Lossius A; Johansen JN; Vartdal F; Robins H; Jūratė Šaltytė B; Holmøy T; Olweus J
    Eur J Immunol; 2014 Nov; 44(11):3439-52. PubMed ID: 25103993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time.
    Iancu EM; Corthesy P; Baumgaertner P; Devevre E; Voelter V; Romero P; Speiser DE; Rufer N
    J Immunol; 2009 Jul; 183(1):319-31. PubMed ID: 19542443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.